Genomic sequences of six botulinum neurotoxin-producing strains representing three clostridial species illustrate the mobility and diversity of botulinum neurotoxin genes

Infection, Genetics and Evolution

Volumn 30, Issue , 2015, Pages 102-113

  Smith, Theresa J ^a   Hill, Karen K ^b   Xie, Gary ^b   Foley, Brian T ^c   Williamson, Charles H D ^d   Foster, Jeffrey T ^d   Johnson, Shannon L ^b   Chertkov, Olga ^b   Teshima, Hazuki ^b   Gibbons, Henry S ^e   Johnsky, Lauren A ^e   Karavis, Mark A ^e,g   Smith, Leonard A ^f  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

^d NORTHERN ARIZONA UNIVERSITY   (United States)

^e EDGEWOOD CHEMICAL BIOLOGICAL CENTER   (United States)

^f U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

^g Aberdeen Proving Ground   (United States)

Author keywords

Botulinum neurotoxin; Clostridium argentinense; Clostridium baratii; Clostridium botulinum

Indexed keywords

BOTULINUM TOXIN; NEUROTOXIN; BACTERIAL DNA;

ARTICLE; BACTERIAL STRAIN; CLOSTRIDIA; CLOSTRIDIUM ARGENTINENSE; CLOSTRIDIUM BARATII; CLOSTRIDIUM BOTULINUM; CONTIG MAPPING; CONTROLLED STUDY; GENE INSERTION; GENE INSERTION SEQUENCE; GENE LOCATION; GENE SEQUENCE; GENETIC CONSERVATION; GENETIC VARIABILITY; HORIZONTAL GENE TRANSFER; NONHUMAN; SEROTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES DIFFERENCE; BACTERIAL GENOME; CLOSTRIDIUM; CLOSTRIDIUM INFECTION; FOOD CONTROL; GENETICS; HUMAN; MICROBIOLOGY; MULTIGENE FAMILY; PATHOGENICITY; PHYLOGENY; SEQUENCE ALIGNMENT;

CLOSTRIDIUM ARGENTINENSE; CLOSTRIDIUM BARATII; CLOSTRIDIUM BOTULINUM;

BOTULINUM TOXINS; CLOSTRIDIUM; CLOSTRIDIUM INFECTIONS; DNA, BACTERIAL; ENVIRONMENTAL MICROBIOLOGY; FOOD MICROBIOLOGY; GENE TRANSFER, HORIZONTAL; GENOME, BACTERIAL; HUMANS; MULTIGENE FAMILY; PHYLOGENY; SEQUENCE ALIGNMENT;

EID: 84919881274     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.12.002     Document Type: Article

References (63)

1. Arnon S.S., Schechter R., Maslanka S.E., Jewell N.P., Hatheway C.L. Human botulism immune globulin for the treatment of infant botulism. N. Engl. J. Med. 2006, 354:462-471.
2. Aureli P., Fenicia L., Pasolini B., Gianfranceschi M., McCroskey L.M., Hatheway C.L. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J. Infect. Dis. 1986, 154:207-211.
3. Aziz R.K., Bartels D., Best A.A., DeJongh M., Disz T., Edwards R.A., Formsma K., Gerdes S., Glass E.M., Kubal M., Meyer F., Olsen G.J., Olson R., Osterman A.L., Overbeek R.A., McNeil L.K., Paarmann D., Paczian T., Parrello B., Pusch G.D., Reich C., Stevens R., Vassieva O., Vonstein V., Wilke A., Zagnitko O. The RAST Server: rapid annotations using subsystems technology. BMC Genomics 2008, 9:75.
4. Barash J.R., Arnon S.S. Dual toxin-producing strain of Clostridium botulinum type Bf isolated from a California patient with infant botulism. J. Clin. Microbiol. 2004, 42:1713-1715.
5. Barash J.R., Tang T.W., Arnon S.S. First case of infant botulism caused by Clostridium baratii type F in California. J. Clin. Microbiol. 2005, 43:4280-4282.
6. Bennett S. Solexa Ltd. Pharmacogenomics 2004, 5:433-438.
7. Bhandari M., Campbell K.D., Collins M.D., East A.K. Molecular characterization of the clusters of genes encoding the botulinum neurotoxin complex in Clostridium botulinum (Clostridium argentinense) type G and nonproteolytic Clostridium botulinum type B. Curr. Microbiol. 1997, 35:207-214.
8. Carter A.T., Mason D.R., Grant K.A., Franciosa G., Aureli P., Peck M.W. Further characterization of proteolytic Clostridium botulinum type A5 reveals that neurotoxin formation is unaffected by loss of the cntR (botR) promoter sigma factor binding site. J. Clin. Microbiol. 2010, 48:1012-1013.
9. Carter A.T., Stringer S.C., Webb M.D., Peck M.W. The type F6 neurotoxin gene cluster locus of group II Clostridium botulinum has evolved by successive disruption of two different ancestral precursors. Genome Biol. Evol. 2013, 5:1032-1037.
10. CDC Botulism in the United States. Handbook for Epidemiologists, Clinicians, and Laboratory Workers 1998, 1899-1996. CDC, Atlanta, GA. Prevention, C.f.D.C.a. (Ed.).
11. CDC Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E. MMWR 2010, 59:299.
12. Collins M.D., East A.K. Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins. J. Appl. Microbiol. 1998, 84:5-17.
13. Dineen S.S., Bradshaw M., Karasek C.E., Johnson E.A. Nucleotide sequence and transcriptional analysis of the type A2 neurotoxin gene cluster in Clostridium botulinum. FEMS Microbiol. Lett. 2004, 235:9-16.
14. Dover N., Barash J.R., Arnon S.S. Novel Clostridium botulinum toxin gene arrangement with subtype A5 and partial subtype B3 botulinum neurotoxin genes. J. Clin. Microbiol. 2009, 47:2349-2350.
15. Dover N., Barash J.R., Hill K.K., Davenport K.W., Teshima H., Xie G., Arnon S.S. Clostridium botulinum strain Af84 contains three neurotoxin gene clusters: bont/A2, bont/F4 and bont/F5. PLoS ONE 2013, 8:e61205.
16. Dupuy B., Raffestin S., Matamouros S., Mani N., Popoff M.R., Sonenshein A.L. Regulation of toxin and bacteriocin gene expression in Clostridium by interchangeable RNA polymerase sigma factors. Mol. Microbiol. 2006, 60:1044-1057.
17. Edgar R.C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010, 26:2460-2461.
18. Eklund M.W., Poysky F.T., Wieler D.I. Characteristics of Clostridium botulinum type F isolated from the Pacific Coast of the United States. Appl. Microbiol. 1967, 15:1316-1323.
19. Eklund M.W., Poysky F.T., Mseitif L.M., Strom M.S. Evidence for plasmid-mediated toxin and bacteriocin production in Clostridium botulinum type G. Appl. Environ. Microbiol. 1988, 54:1405-1408.
20. Engelthaler D.M., Hicks N.D., Gillece J.D., Roe C.C., Schupp J.M., Driebe E.M., Gilgado F., Carriconde F., Trilles L., Firacative C., Ngamskulrungroj P., Castañeda E., dos Santos Lazera M., Melhem M.S.C., Pérez-Bercoff A., Huttley G., Sorrell T.C., Voelz K., May R.C., Fisher M.C., Thompson G.R., Lockhart S.R., Keim P., Meyer W. Cryptococcus gattii in North American Pacific Northwest: whole-population genome analysis provides insights into species evolution and dispersal. mBio 2014, 5:e01414-e01464.
21. Fillo S., Giordani F., Anniballi F., Gorge O., Ramisse V., Vergnaud G., Riehm J.M., Scholz H.C., Splettstoesser W.D., Kieboom J., Olsen J.S., Fenicia L., Lista F. Clostridium botulinum group I strain genotyping by 15-locus multilocus variable-number tandem-repeat analysis. J. Clin. Microbiol. 2011, 49:4252-4263.
22. Franciosa G., Maugliani A., Scalfaro C., Aureli P. Evidence that plasmid-borne botulinum neurotoxin type B genes are widespread among Clostridium botulinum serotype B strains. PLoS ONE 2009, 4:e4829.
23. Gardner S.N., Hall B.G. When whole-genome alignments just won't work: kSNP v2 software for alignment-free SNP discovery and phylogenetics of hundreds of microbial genomes. PLoS ONE 2013, 8:e81760.
24. Gimenez D.F., Ciccarelli A.S. Another type of Clostridium botulinum. Zentralbl. Bakteriol. Orig. 1970, 215:221-224.
25. Gonzalez-Escalona N., Timme R., Raphael B.H., Zink D., Sharma S.K. Whole-genome single-nucleotide-polymorphism analysis for discrimination of Clostridium botulinum group I strains. Appl. Environ. Microbiol. 2014, 80:2125-2132.
26. Gu S., Jin R. Assembly and function of the botulinum neurotoxin progenitor complex. Curr. Top. Microbiol. Immunol. 2013, 364:21-44.
27. Guindon S., Dufayard J.F., Lefort V., Anisimova M., Hordijk W., Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst. Biol. 2010, 59:307-321.
28. Gupta A., Sumner C.J., Castor M., Maslanka S.E., Sobel J. Adult botulism type F in the United States, 1981-2002. Neurology 2005, 65:1694-1700.
29. Hall J.D., McCroskey L.M., Pincomb B.J., Hatheway C.L. Isolation of an organism resembling Clostridium baratii which produces type F botulinal toxin from an infant with botulism. J. Clin. Microbiol. 1985, 21:654-655.
30. Hannett, G.E., Schaffzin, J.K., Davis, S.W., Fage, M.P., Johnson, G.S., Schoonmaker-Bopp, D., Dumas, N., Musser, K., 2010. Two cases of botulism due to Clostridium baratii production of type F botulism toxin, Anaerobe 2010, Philadelphia, PA, p. 8.
31. Hatheway C.L., McCroskey L.M. Examination of feces and serum for diagnosis of infant botulism in 336 patients. J. Clin. Microbiol. 1987, 25:2334-2338.
32. Hemmerich C., Buechlein A., Podicheti R., Revanna K.V., Dong Q. An Ergatis-based prokaryotic genome annotation web server. Bioinformatics 2010, 26:1122-1124.
33. Hill K.K., Smith T.J. Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes. Curr. Top. Microbiol. Immunol. 2013, 364:1-20.
34. Hill K.K., Smith T.J., Helma C.H., Ticknor L.O., Foley B.T., Svensson R.T., Brown J.L., Johnson E.A., Smith L.A., Okinaka R.T., Jackson P.J., Marks J.D. Genetic diversity among botulinum neurotoxin-producing clostridial strains. J. Bacteriol. 2007, 189:818-832.
35. Hill K.K., Xie G., Foley B.T., Smith T.J., Munk A.C., Bruce D., Smith L.A., Brettin T.S., Detter J.C. Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strains. BMC Biol. 2009, 7:66.
36. Jacobson M.J., Lin G., Raphael B., Andreadis J., Johnson E.A. Analysis of neurotoxin cluster genes in Clostridium botulinum strains producing botulinum neurotoxin serotype A subtypes. Appl. Environ. Microbiol. 2008, 74:2778-2786.
37. Katoh K., Standley D.M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 2013, 30:772-780.
38. Kirma N., Ferreira J.L., Baumstark B.R. Characterization of six type A strains of Clostridium botulinum that contain type B toxin gene sequences. FEMS Microbiol. Lett. 2004, 231:159-164.
39. Kurtz S., Phillippy A., Delcher A.I., Smoot M., Shumway M., Antonescu C., Salzberg S.L. Versatile and open software for comparing large genomes. Genome Biol. 2004, 5:R12.
40. Leclair D., Fung J., Isaac-Renton J.L., Proulx J.F., May-Hadford J., Ellis A., Ashton E., Bekal S., Farber J.M., Blanchfield B., Austin J.W. Foodborne botulism in Canada, 1985-2005. Emerg. Infect. Dis. 2013, 19:961-968.
41. Lewis P.O. A likelihood approach to estimating phylogeny from discrete morphological character data. Syst. Biol. 2001, 50:913-925.
42. Margulies M., Egholm M., Altman W.E., Attiya S., Bader J.S., Bemben L.A., Berka J., Braverman M.S., Chen Y.J., Chen Z., Dewell S.B., Du L., Fierro J.M., Gomes X.V., Godwin B.C., He W., Helgesen S., Ho C.H., Irzyk G.P., Jando S.C., Alenquer M.L., Jarvie T.P., Jirage K.B., Kim J.B., Knight J.R., Lanza J.R., Leamon J.H., Lefkowitz S.M., Lei M., Li J., Lohman K.L., Lu H., Makhijani V.B., McDade K.E., McKenna M.P., Myers E.W., Nickerson E., Nobile J.R., Plant R., Puc B.P., Ronan M.T., Roth G.T., Sarkis G.J., Simons J.F., Simpson J.W., Srinivasan M., Tartaro K.R., Tomasz A., Vogt K.A., Volkmer G.A., Wang S.H., Wang Y., Weiner M.P., Yu P., Begley R.F., Rothberg J.M. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005, 437:376-380.
43. Moriishi K., Koura M., Abe N., Fujii N., Fujinaga Y., Inoue K., Oguma K. Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms. Biochim. Biophys. Acta 1996, 1307:123-126.
44. Nawrocki E.P., University W. Structural RNA Homology Search and Alignment Using Covariance Models 2009, Washington University, Saint Louis, MO.
45. Popoff M., Marvaud J.C. Structural and genomic features of clostridial neurotoxins. The Comprehensive Sourcebook of Bacterial Protein Toxins 1999, 174-201. Academic Press. J.E. Alouf, M.R. Popoff (Eds.).
46. Raphael B.H., Luquez C., McCroskey L.M., Joseph L.A., Jacobson M.J., Johnson E.A., Maslanka S.E., Andreadis J.D. Genetic homogeneity of Clostridium botulinum type A1 strains with unique toxin gene clusters. Appl. Environ. Microbiol. 2008, 74:4390-4397.
47. Raphael B.H., Choudoir M.J., Luquez C., Fernandez R., Maslanka S.E. Sequence diversity of genes encoding botulinum neurotoxin type F. Appl. Environ. Microbiol. 2010, 76:4805-4812.
48. R-Core-Team R: A Language and Environment for Statistical Computing 2014, R Foundation for Statical Computing, Vienna, Austria.
49. Sakaguchi Y., Hosomi K., Uchiyama J., Ogura Y., Umeda K., Sakaguchi M., Kohda T., Mukamoto M., Misawa N., Matsuzaki S., Hayashi T., Kozaki S. Draft genome sequence of Clostridium botulinum Type B strain Osaka05, isolated from an infant patient with botulism in japan. Genome Announc. 2014, 2.
50. Schliep K.P. Phangorn: phylogenetic analysis in R. Bioinformatics 2011, 27:592-593.
51. Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 2014, 30:2068-2069. 10.1093/bioinformatics/btu153.
52. Skarin H., Segerman B. Horizontal gene transfer of toxin genes in Clostridium botulinum: involvement of mobile elements and plasmids. Mobile Genet. Elem. 2011, 1:213-215.
53. Smith T.J. Clostridium botulinum genomes and genetic diversity. Molecular Aspects of Botulinum Neurotoxins 2013, Springer-Verlag. K. Foster (Ed.).
54. Smith T.J., Lou J., Geren I.N., Forsyth C.M., Tsai R., Laporte S.L., Tepp W.H., Bradshaw M., Johnson E.A., Smith L.A., Marks J.D. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect. Immun. 2005, 73:5450-5457.
55. Smith T.J., Hill K.K., Foley B.T., Detter J.C., Munk A.C., Bruce D.C., Doggett N.A., Smith L.A., Marks J.D., Xie G., Brettin T.S. Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids. PLoS ONE 2007, 2:e1271.
56. Smith T.J., Roxas-Duncan V.I., Smith L.A. Botulinum neurotoxins as biothreat agents. J. Bioterror. Biodef. 2012, S7.
57. Sonnabend O., Sonnabend W., Heinzle R., Sigrist T., Dirnhofer R., Krech U. Isolation of Clostridium botulinum type G and identification of type G botulinal toxin in humans: report of five sudden unexpected deaths. J. Infect. Dis. 1981, 143:22-27.
58. Sonnabend W.F., Sonnabend U.P., Krech T. Isolation of Clostridium botulinum type G from Swiss soil specimens by using sequential steps in an identification scheme. Appl. Environ. Microbiol. 1987, 53:1880-1884.
59. Stamatakis A. RAxML Version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 2014, btu033.
60. Stamatakis A., Hoover P., Rougemont J. A rapid bootstrap algorithm for the RAxML web servers. Syst. Biol. 2008, 57:758-771.
61. Zerbino D.R., Birney E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 2008, 18:821-829.
62. Zhang Z., Hintsa H., Chen Y., Korkeala H., Lindstrom M. Plasmid-borne type E neurotoxin gene clusters in Clostridium botulinum strains. Appl. Environ. Microbiol. 2013, 79:3856-3859.
63. Zhou Y., Sugiyama H., Nakano H., Johnson E.A. The genes for the Clostridium botulinum type G toxin complex are on a plasmid. Infect. Immun. 1995, 63:2087-2091.